HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. (HTGMQ) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001169987 · HTGMQ · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001169987 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
HTG Molecular Diagnostics, Inc. (OTC: HTGMQ) has submitted 669 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001169987, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is HTG Molecular Diagnostics, Inc.'s most comprehensive regulatory disclosure. The most recent HTG Molecular Diagnostics, Inc. 10-K was filed on 2023-03-30 for fiscal year ending 2023. Historical HTGMQ 10-K annual reports are available from 2002 through 2023.
Investors researching HTG Molecular Diagnostics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
HTGMQ SEC Filings · 8 questionsHTG Molecular Diagnostics, Inc. (HTGMQ) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 669 filings and access original documents at no cost. HTG Molecular Diagnostics, Inc.'s CIK is 0001169987.